34
Participants
Start Date
July 31, 2012
Primary Completion Date
November 30, 2013
Study Completion Date
November 30, 2013
Gabapentin ER
"Patient who are on gralise will report efficacy by rating his or her pain rating on a digital pain scale (11 points) from 0 to 10 on each scheduled clinical visits, which will be compared to their pain level at baseline.~In addition, patients will also record the doses and any adverse effects that might arise during the trial in a diary provided by the study. All information will be recorded in a paper diary that will be followed by coordinator during each follow up visits."
Center for Clinical Research, Winston-Salem
Collaborators (1)
Depomed
INDUSTRY
The Center for Clinical Research, Winston-Salem, NC
OTHER